Abstract: We review the HSLMI universe for potential candidates for the upcoming HSI August 2026 review. Three stocks stand out as ADD candidates this cycle, one of them high conviction. We also highlight substantial FF and weight changes for CATL.
SINOPHARM, MMG, CHINA RESOURCES MIXC LIFESTYLE SERVICES, HUA HONG SEMI, J&T EXPRESS, INNOVENT BIOLOGICS, ZIJIN GOLD INTL, WUXI XDC, KE, CHALCO, CATL, BEONE MEDICINES LTD-H, HKT-SS, SINO LAND
Research on index reviews and inclusion events across Asia Pacific, including MSCI, Hang Seng (HSI, HSCEI, HSCI), HS TECH, CSI 300, STAR50, NIFTY and Stock Connect changes. Coverage runs from rebalance forecasts through post-announcement positioning, pre-implementation updates and post-implementation reviews, using the price patterns of past events.
Interested in the full report? Get in touch with our team.
We will review your request. Once approved, the report will be sent to your company email.
Thank you! We will review your request and email the report to you, usually within 1 business day.